focal.vc

blog

less how-safes-work.md

Sep 4, 2026 · blog

What Happens After a Startup and Investor Sign a SAFE

A SAFE lets a startup receive cash now while giving the investor a contractual right tied to future equity. The investor does not receive shares immediately. Conversion usually happens when the company completes a priced equity round, although a sale, dissolution, or another event can produce a different contractual outcome.

Overview

SAFE stands for Simple Agreement for Future Equity. In the U.S. startup-financing context, it is commonly used to defer the company valuation and share issuance that would happen in a priced round. Carta describes a SAFE as a contract for future equity rather than current ownership.

A standard SAFE is not debt. It generally has no accruing interest or maturity date, according to Cooley GO. Before conversion, the holder is not yet a shareholder and generally has no voting rights, as Carta explains.

That structure creates a clear exchange at signing: the company gets capital, and the investor gets contractual rights rather than stock or a debt claim due on a fixed date. Those rights can still be valuable, but their value depends on the SAFE’s terms and what happens to the company.

The word “SAFE” does not settle every calculation. The form version, valuation cap, discount, capitalization definition, event provisions, amendments, and side letters can all affect the result. The signed agreement controls.

From signing to conversion, exit, or dissolution

A SAFE can follow several paths after the investor funds the company. A priced financing is the usual conversion event, but it is not the only possible outcome. A sale and a dissolution have separate mechanics, and a SAFE can remain outstanding if no specified event occurs.

The key is to separate these events rather than treating all of them as “conversion.” Cooley GO identifies a priced financing as the usual trigger, while AngelList describes separate acquisition economics that may involve cash or equity treatment.

  • Event: Signing and funding
    Investor position: The investor pays the purchase amount and receives the SAFE contract, not shares. The company receives the cash.
    Likely contractual outcome: The SAFE remains outstanding until a contractual event occurs or the instrument terminates under its terms.
    What must be checked: Confirm the purchase amount, payment mechanics, form version, signatures, and any closing conditions.
  • Event: Priced equity financing
    Investor position: The investor still holds the SAFE immediately before conversion.
    Likely contractual outcome: The SAFE usually converts into shares using the applicable cap price, discount price, or another price specified by the agreement. Carta identifies the first priced round as the most common trigger.
    What must be checked: Check the definition of equity financing, the conversion security, the capitalization denominator, and whether the cap or discount produces the applicable price.
  • Event: Sale or other liquidity event before conversion
    Investor position: The investor has a contractual claim but may not yet own shares.
    Likely contractual outcome: Depending on the form, the holder may receive a cash amount or an equity-based amount calculated under the agreement. AngelList describes acquisition treatment as a separate choice between return-of-purchase-price and conversion-based economics.
    What must be checked: Read the liquidity-event definition, payment formula, election mechanics, priority, and treatment of transaction proceeds.
  • Event: Dissolution
    Investor position: The SAFE has not converted, and the company is winding down.
    Likely contractual outcome: The agreement may provide a repayment right, but the amount actually recovered depends on the assets remaining after higher-priority obligations. Cooley GO notes that meaningful assets may not remain for SAFE holders.
    What must be checked: Check the dissolution definition, payment order, priority against other claims, available assets, and termination language.
  • Event: No financing, sale, or dissolution trigger
    Investor position: The investor continues to hold the contract without shares, interest, or a maturity deadline under a standard SAFE.
    Likely contractual outcome: The SAFE may remain outstanding indefinitely. Cooley GO explains that it may never convert if the company neither raises future equity financing nor gets acquired.
    What must be checked: Check whether this agreement adds an expiration date, repayment mechanism, consent right, or another nonstandard termination event.

A priced-round conversion issues shares. A sale may instead create cash-or-equity economics, while dissolution concerns the distribution of whatever assets remain. Those outcomes cannot be modeled with one generic “conversion event” assumption.

The absence of a maturity date matters on both sides. A founder does not face the same fixed repayment deadline associated with a convertible note. The investor, however, can wait for an undefined period without receiving stock or accruing interest.

The terms that determine conversion

The number of shares issued on conversion follows a basic relationship:

SAFE shares = purchase amount ÷ conversion price

The difficult part is identifying the conversion price. That requires the valuation cap, discount, priced-round share price, capitalization definition, and SAFE form to work as one system. A lower conversion price gives the SAFE holder more shares for the same purchase amount.

The agreement’s capitalization definition is especially important. It determines which existing shares, options, reserved pool shares, SAFEs, notes, or other securities enter the denominator. A calculator that uses a different denominator can produce a precise answer to the wrong contract.

How valuation caps and discounts set the conversion price

A valuation cap limits the company valuation used to calculate the SAFE’s conversion price. When the priced round values the company above the cap, the cap can give the SAFE holder a lower price per share than the new investors receive. Carta describes the cap as the maximum valuation used for conversion.

A discount works from the priced-round share price instead. If a SAFE has a 20% discount and the relevant round price is $1.00 per share, the discounted conversion price is $0.80. Cooley GO uses this same example.

The core calculations are:

  • Cap price: valuation cap ÷ capitalization denominator defined by the SAFE
  • Discount price: priced-round price × (1 − discount rate)
  • Conversion price: the lower applicable price when both mechanisms are available
  • SAFE shares: purchase amount ÷ conversion price

When a SAFE contains both a cap and a discount, the benefits generally are not stacked. The investor usually receives the mechanism producing the lower price, according to Cooley GO and AngelList.

Suppose the applicable cap price is $0.90 and the discount price is $1.20. The SAFE converts at $0.90 because that price produces more shares. The investor does not first apply the cap and then take an additional discount unless the signed agreement expressly creates that result.

The arithmetic is straightforward only after the denominator and calculation sequence are settled. If the SAFE defines capitalization differently from the model, both the cap price and resulting share count change.

Pre-money and post-money SAFEs

Pre-money and post-money SAFEs differ in how SAFE conversion enters the capitalization calculation. That distinction changes how clearly a founder can estimate the ownership sold before the next priced round.

Cooley GO explains that a pre-money SAFE calculation does not include SAFE conversion in the same way as a post-money SAFE. As additional pre-money SAFEs are issued, earlier holders can be affected by later instruments, making the final ownership harder to predict.

Post-money SAFEs make the stake sold through each SAFE more legible before the priced round. In a simple cap-based illustration, dividing the SAFE amount by the post-money cap provides a useful ownership shortcut. A $500,000 SAFE with a $5 million post-money cap suggests 10% before subsequent priced-round dilution, as AngelList illustrates.

That 10% is not necessarily the investor’s final ownership after the financing. New shares issued to priced-round investors dilute the SAFE holder. Option-pool changes can also affect the cap table, with the allocation depending on the agreement and financing sequence.

Post-money clarity therefore answers a narrower question: how much ownership the SAFE is designed to represent before specified later dilution. It does not freeze the investor’s percentage through the priced round. Mantle’s SAFE explanation shows how new investors and option-pool changes reduce SAFE ownership after conversion.

Worked example: SAFE conversion through the priced round

Start with a hypothetical $500,000 post-money SAFE at a $5 million valuation cap, with no discount. Assume the cap determines conversion, there are no other convertible instruments, and no option-pool increase or other issuance changes the ownership base. This is an ownership illustration, not a model of a particular signed agreement.

The estimated SAFE stake before the new priced-round investment is:

$500,000 ÷ $5,000,000 = 10%

AngelList uses this amount-and-cap illustration to explain post-money SAFE ownership. The percentage describes the position before subsequent financing dilution. It is not a promise of 10% after the next round.

Now suppose new investors buy 20% of the company in a priced round. Assume the SAFE investor contributes no additional money and all existing positions share that dilution proportionally. Existing positions retain 80% of their previous percentages, so the SAFE holder's stake becomes:

10% × 80% = 8%

The SAFE represented 10% before the new investment and 8% afterward. Both statements can be correct because they describe different stages.

This shortcut does not determine a real share price or share count. Those calculations require the agreement's capitalization definition. A round priced below or near the cap, an option-pool increase, another convertible instrument, or a different conversion provision can change the result. Use the signed form and the financing documents together before relying on a calculator.

SAFEs, convertible notes, and priced equity

SAFEs, convertible notes, and priced equity can all fund a startup, but they give the investor different rights at closing. The central distinction is whether the investor receives a future contractual right, a debt instrument, or shares immediately.

  • SAFE: The company receives capital, while the investor receives a contract tied to later events. A standard SAFE has no accruing interest or maturity date, and shares are usually issued when a priced financing triggers conversion. The investor generally has no shareholder voting rights before then.
  • Convertible note: The investor receives debt that may later convert into equity. Unlike a standard SAFE, a convertible note carries debt features such as interest and a maturity date, as Mercury explains.
  • Priced equity: The company and investors set a valuation and price per share at the current closing. The investors receive shares immediately rather than waiting for conversion. Carta contrasts priced rounds and SAFEs on this point.

A SAFE defers formal pricing, but it does not defer all dilution economics. The cap and discount can already shape how much ownership will be issued. Founders who track only the cash raised, without modeling conversion, can underestimate the stake committed to SAFE holders.

A convertible note adds a time dimension. Interest can increase the amount that converts, and maturity creates a date at which the note’s terms become immediately relevant. The exact outcome at maturity depends on the note, so it cannot be inferred from SAFE mechanics.

Priced equity makes share issuance and the new investor’s ownership visible at closing. It can also address voting, board, information, and other shareholder rights directly. A SAFE usually postpones those equity documents until conversion, although side letters can grant particular contractual rights earlier.

No instrument is universally better. A SAFE may fit when both sides accept deferred pricing and uncertain timing. A convertible note may fit when the parties want a debt structure with maturity and interest. A priced round may fit when immediate ownership and governance terms need to be settled. The decision depends on the company’s financing objective and the rights each side is prepared to negotiate.

Benefits and risks for founders and investors

A SAFE’s apparent simplicity shifts decisions into the future rather than eliminating them. Each founder benefit has an investor-side tradeoff or a later cap-table consequence.

  • Deferred valuation versus ownership uncertainty. A SAFE lets the company raise without setting the same formal valuation and price per share used in a priced round. That can reduce immediate negotiation, but both sides still need to understand the cap and discount. Those terms can materially determine ownership later.
  • No maturity pressure versus an indefinite wait. A standard SAFE has no maturity date or accruing interest, according to Cooley GO. The founder avoids a debt-style deadline, while the investor may wait indefinitely if no conversion or liquidity event occurs.
  • Limited pre-conversion control versus limited investor rights. Because the holder is not yet a shareholder, founders generally do not grant ordinary shareholder voting rights at signing. The investor receives less immediate control and no current stock ownership, as Carta explains.
  • Simple issuance versus accumulated dilution. A company can sign multiple SAFEs without issuing shares immediately. That makes it easy to lose sight of the aggregate ownership promised. AngelList warns that founders can underestimate dilution and end up with less control than expected.
  • Early upside versus company-outcome risk. A favorable cap or discount can give an investor more shares than the same investment at the priced-round price. If the company never reaches financing or a sale, however, the investor may never receive equity. Dissolution recovery can also be limited by the assets remaining.

The practical founder test is not whether the SAFE looks short. It is whether the company has modeled the ownership produced by every outstanding instrument under plausible financing terms. A one-page economic summary should still reconcile with the cap table.

The practical investor test is whether the conversion and event rights compensate for waiting without current shares, interest, or a maturity deadline. A low conversion price can improve the economics of a successful financing, but it does not make financing, acquisition, or repayment certain.

Capital is also only one part of the 0-to-1 work. SAFE terms determine contractual economics; they do not change the operating work required to reach the next company milestone. Our Working with focal approach centers on working closely with founders through those early challenges, but that support does not alter a SAFE’s conversion formula or guarantee an outcome.

What to verify in the actual SAFE

Before relying on a calculator or ownership shortcut, map the model to the signed SAFE. A small change in the capitalization definition or event language can change the shares issued, payout mechanics, or participation rights.

1. Identify the form and date. Record whether the document is labeled pre-money or post-money and which source form it references. Some documents state that they are unmodified except for blanks and bracketed terms; AngelList recommends extra scrutiny when that representation is absent.

2. Check every modification. A document can be called a SAFE while departing materially from familiar terms. For example, a 2017 agreement filed with the SEC included date-dependent discounts, accrued unpaid dividends in a conversion formula, and detailed expiration provisions. Those are features of that filed agreement, not assumptions to apply to another SAFE.

3. Locate the cap and discount. Confirm whether the SAFE has a valuation cap, a discount, both, or neither. Then check how the agreement selects the conversion price. A model should not stack the cap and discount when the contract treats them as alternatives.

4. Read the capitalization definition line by line. Determine whether it includes issued common shares, preferred shares, granted options, unissued pool shares, other SAFEs, convertible notes, or warrants. Confirm whether a planned option-pool increase enters the denominator and at what stage.

5. Separate financing, liquidity, and dissolution provisions. For a priced financing, identify the triggering threshold, security issued, and conversion formula. For a liquidity event, identify cash and conversion-based outcomes. For dissolution, check priority and the amount payable from remaining assets.

6. Review termination and transfer language. Determine when the SAFE terminates, whether it can remain outstanding without a trigger, and what restrictions apply to assignment or transfer. These clauses matter if the expected priced round never happens.

7. Find every side letter. A side letter can add pro rata participation, information rights, or another negotiated term that does not appear in the main SAFE. Model the financing from the complete document set rather than the SAFE alone.

8. Separate contractual economics from other assessments. The share calculation does not settle tax treatment, accounting classification, or the securities-law steps for issuing the instrument. Those questions require review under the company’s facts, jurisdiction, offering structure, and current rules.

The final check is reconciliation. The conversion price multiplied by SAFE shares should equal the applicable purchase amount, subject to the contract’s treatment of any additional amount. Every holder’s post-round percentage should use the same total-share denominator, and all percentages should sum to approximately 100% after rounding.

MFN and pro rata rights

An MFN, or most favored nation provision, addresses later SAFE terms. It can let an earlier investor adopt more favorable terms offered to a later SAFE investor. Cooley GO explains that an MFN holder may have the option to receive those later terms.

The decision point is whether adoption happens automatically or requires the holder to elect it. The clause should also state which later terms qualify, the election process, and whether the holder adopts an entire later instrument or only specified economics.

Pro rata rights address a different question. They give an investor an opportunity to buy additional securities in a later financing to preserve some or all of its ownership percentage. They do not change the original SAFE’s cap or discount.

Pro rata participation is not automatic under standard post-money SAFE treatment described by LTSE. Cooley GO notes that the right may instead be granted through a separate side letter. Confirm the eligibility threshold, financing scope, notice process, purchase limit, and expiration terms in the actual documents.

If you want to start a financing conversation with us, use Pitch us.

Explore founder resources ↗

(END) — back to blog/ · pitch us

next: Reading a VC Term Sheet: Economics, Control, and Closing

© 2026 focal — hand-built, no trackers, screen-reader aware (type 'a11y'). view source; there's a note for you. or: curl focal.vc · working with focal · terms & privacy

Command palette

Jump anywhere